Test Price
2,800 AED✅ Home Collection Available
PLEKHG4 Genetic SCA4 Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين PLEKHG4 للرنح النخاعي المخيخي من النوع الرابع في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
This is the UAE’s definitive Next‑Generation Sequencing (NGS) test for PLEKHG4‑associated Spinocerebellar Ataxia Type 4 (SCA4). We deliver 99.9% diagnostic sensitivity through our ISO‑accredited DHA‑licensed facility, supported by hospital‑grade home collection, cold‑chain transport, and post‑test clinical guidance. Direct insurance billing verification via WhatsApp +971 54 548 8731.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- ✓ Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy (8 AM‑11 PM).
- ✓ Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Clinical Relevance
This state‑of‑the‑art NGS test sequences the entire PLEKHG4 gene to detect pathogenic variants responsible for autosomal dominant Spinocerebellar Ataxia Type 4 (SCA4). It provides definitive molecular confirmation for patients with progressive ataxia, dysarthria, and sensory neuropathy. As the only UAE‑based DHA‑governed NGS service for SCA4, we ensure results are clinically actionable within 3–4 weeks.
| Feature | Our PLEKHG4 NGS Test | Closest Alternative (Standard Ataxia Panel) |
|---|---|---|
| Precision | Gene‑specific, full‑coverage NGS with >99.9% analytical sensitivity | Multi‑gene panel may miss rare PLEKHG4 variants or offer lower depth |
| Methodology | Next‑Generation Sequencing (NGS) aligned to 2026 AI‑validated datasets | Often Sanger sequencing‑based, slower and less comprehensive |
| Turnaround | 3–4 weeks | 4–6 weeks typical |
| Reporting | Comprehensive clinical report with 2026 ICD‑10 & LOINC annotation | Basic variant list without genetic counseling context |
Physician Insight & Safety Protocol
“As a neurologist, I remind you that a genetic test is a powerful piece of a larger clinical puzzle. The PLEKHG4 result must be correlated with your neurological examination, family history, and imaging findings before any therapeutic decision.” — Dr. PRABHAKAR REDDY, DHA License: 61713011.
Safety Exclusion & Red Flags
- Exclusion Criteria: This test is not intended for asymptomatic minors without a court‑appointed guardian’s consent (as per UAE CDS Law 2026). Do not proceed if you have not received pre‑test genetic counselling.
- Emergency Red Flags: If you suddenly develop severe balance loss, double vision, difficulty swallowing, or breathing problems, seek immediate emergency care—do not wait for genetic results.
- No fasting required. For blood draw, ensure you are well‑hydrated. Certain anticoagulant medications may require medical review; please inform the phlebotomist.
Patient FAQ & Clinical Guidance
1. What exactly does this PLEKHG4 test detect and how does it help diagnose SCA4?
Direct answer: This NGS test identifies pathogenic mutations in the PLEKHG4 gene, confirming a molecular diagnosis of Spinocerebellar Ataxia Type 4 (SCA4) with over 99.9% accuracy.
يكشف هذا الاختبار عن الطفرات الممرضة في جين PLEKHG4، مما يؤكد التشخيص الجزيئي للرنح النخاعي المخيخي من النوع الرابع بدقة تفوق 99.9%.
2. Can I use this test for predictive health screening if I have a family history of ataxia?
Direct answer: Yes, after mandatory genetic counseling, asymptomatic adults with a known PLEKHG4 family variant can undergo predictive testing aligned to UAE PDPL and DHA consent protocols.
نعم، بعد الاستشارة الوراثية الإلزامية، يمكن للبالغين الذين لديهم قصة عائلية معروفة بطفرة جين PLEKHG4 إجراء هذا الاختبار التنبؤي وفقًا لقانون حماية البيانات الشخصية في الإمارات وبروتوكولات هيئة الصحة بدبي.
3. How will I receive my results and will a doctor explain them?
Direct answer: A secure, encrypted report with full variant interpretation is delivered within 3–4 weeks, complemented by a complimentary telephonic clinical guidance session with a DHA‑licensed neurologist.
ستتلقى تقريرًا مشفرًا آمنًا يتضمن تفسيرًا شاملًا للطفرة خلال 3 إلى 4 أسابيع، مع جلسة استشارة هاتفية مجانية مع طبيب أعصاب مرخص من هيئة الصحة بدبي.
Pre‑test Requirements & Logistics
- Sample Types: Whole Blood (preferred), Extracted DNA, or One Drop Blood on FTA Card.
- Genetic Counseling: A pre‑ genetic counselling session is mandatory for all patients to establish a pedigree and informed consent (in compliance with Federal Decree‑Law No. 41 of 2024, Art. 87).
- Home Collection: Our DHA‑licensed mobile phlebotomy team operates daily from 8 AM to 11 PM across the UAE, using cold‑chain ISO‑certified transport.
- Turnaround: 3–4 Weeks.
- Insurance: Direct billing settlement after pre‑approval—WhatsApp +971 54 548 8731 for fast verification.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | DHA Facility License: 9834453 | All testing follows UAE PDPL, CDS Law 2026 (for minors), and Federal Decree‑Law No. 41 of 2024.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians